COLUCID PHARMACEUTICALS, INC.

Profile

Company Names

COLUCID PHARMACEUTICALS, INC.

Addresses

2520 MERIDIAN PARKWAY, SUITE 400, DURHAM, NC 27713

2520 MERIDIAN PARKWAY, SUITE 400, DURHAM, X1 27713

2530 MERIDIAN PARKWAY, SUITE 300, DURHAM, NC 27713

Phone Numbers

919-806-4304
919-649-6184

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$54,549,981.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-01-12 
$37,100,000.00 
$37,100,000.00 
$0.00 
Equity 
2
2011-02-25 
$8,250,000.00 
$9,500,000.00 
$1,250,000.00 
Debt 
1
2009-01-20 
$9,199,981.00 
$13,799,968.00 
$4,599,987.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DANIEL 
L 
BOEGLIN 
EXECUTIVE OFFICER
COLUCID PHARMACEUTICALS, INC.
DANIEL 
L. 
BOEGLIN 
EXECUTIVE OFFICER
COLUCID PHARMACEUTICALS, INC.
MARTIN 
 
EDWARDS 
DIRECTOR
LOGICAL THERAPEUTICS INC   |  TARSA THERAPEUTICS, INC.   |  COLUCID PHARMACEUTICALS, INC.   |  HARMONY BIOSCIENCES II, INC.   |  STARGAZER PHARMACEUTICALS, INC.   |  INOZYME PHARMA, INC.   |  VERONA PHARMA PLC   |  MORPHIC HOLDING, INC.
TIMOTHY 
C 
GUPTON 
EXECUTIVE OFFICER
COLUCID PHARMACEUTICALS, INC.
TIMOTHY 
C. 
GUPTON 
EXECUTIVE OFFICER
COLUCID PHARMACEUTICALS, INC.
BERNICE 
 
KUCA 
EXECUTIVE OFFICER
COLUCID PHARMACEUTICALS, INC.
LUC 
 
MARENGERE 
DIRECTOR
COLUCID PHARMACEUTICALS, INC.   |  ACER THERAPEUTICS INC.   |  RAPID MICRO BIOSYSTEMS, INC.   |  ACCESS VASCULAR, INC.   |  SARKANA PHARMA, INC.   |  VEKTOR MEDICAL, INC.   |  EGG MEDICAL, INC.
RICHARD 
 
MARKHAM 
DIRECTOR
COLUCID PHARMACEUTICALS, INC.   |  VAXART, INC.   |  ANACOR PHARMACEUTICALS INC   |  NEPHROGENEX, INC.
RICHARD 
J. 
MARKHAM 
DIRECTOR
NEPHROGENEX, INC.   |  COLUCID PHARMACEUTICALS, INC.
THOMAS 
P. 
MATHERS 
EXECUTIVE OFFICER, DIRECTOR
COLUCID PHARMACEUTICALS, INC.
ARTHUR 
M 
PAPPAS 
EXECUTIVE OFFICER, DIRECTOR
COLUCID PHARMACEUTICALS, INC.
ARTHUR 
M. 
PAPPAS 
EXECUTIVE OFFICER, DIRECTOR
PV IV CEO FUND, LP   |  CARDIODX INC   |  CHIMERIX INC   |  COLUCID PHARMACEUTICALS, INC.   |  PV V CEO FUND, LP   |  A. M. PAPPAS LIFE SCIENCE VENTURES V, LP
NADIA 
 
RUPNIAK 
EXECUTIVE OFFICER
COLUCID PHARMACEUTICALS, INC.
NADIA 
M. 
RUPNIAK 
EXECUTIVE OFFICER
COLUCID PHARMACEUTICALS, INC.
MATHERS 
P. 
THOMAS 
EXECUTIVE OFFICER, DIRECTOR
COLUCID PHARMACEUTICALS, INC.
JESSE 
I 
TREU 
DIRECTOR
COLUCID PHARMACEUTICALS, INC.
JESSE 
I. 
TREU 
DIRECTOR
ALTEA THERAPEUTICS CORP   |  DP VIII ASSOCIATES, L.P.   |  DOMAIN PARTNERS VIII, L.P.   |  SOMAXON PHARMACEUTICALS, INC.   |  COLUCID PHARMACEUTICALS, INC.   |  VERACYTE, INC.   |  ALDEYRA THERAPEUTICS, INC.
JAMES 
F 
WHITE 
EXECUTIVE OFFICER, DIRECTOR
COLUCID PHARMACEUTICALS, INC.
JAMES 
F. 
WHITE 
EXECUTIVE OFFICER, DIRECTOR
COLUCID PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-01-26
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2015-01-12 
2013-07-11
D/A
Link
PHARMACEUTICALS 
 
NO REVENUES 
Debt 
2011-02-25 
2011-06-28
D/A
Link
PHARMACEUTICALS 
 
$1 - $1,000,000 
Debt 
2011-02-25 
2011-03-03
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Debt 
2011-02-25 
2010-01-26
D/A
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2009-01-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#